Verify Atipamezole

Drug JSON

This is exactly what your browser canonicalizes + SHA-256-hashes

{
  "slug": "atipamezole",
  "nameEn": "Atipamezole",
  "nameTh": "อะติพาเมโซล",
  "class": "α2-adrenergic antagonist — reversal agent for dexmedetomidine/medetomidine (veterinary-only)",
  "mechanism": "TEMPLATE — mechanism pending Thai translation + faculty review (cross-check DailyMed + WHO ATC + PubChem)",
  "brandNamesTh": [
    "Antisedan",
    "Atipam"
  ],
  "indications": [
    {
      "text": "TEMPLATE — indications pending Thai translation + faculty review (cross-check DailyMed + WHO ATC + PubChem)",
      "cites": [
        "dailymed-atipamezole",
        "atc-QV03AB94",
        "pubchem-atipamezole"
      ]
    }
  ],
  "contraindications": [
    {
      "text": "TEMPLATE — contraindications pending Thai translation + faculty review (cross-check DailyMed + WHO ATC + PubChem)",
      "cites": [
        "dailymed-atipamezole",
        "atc-QV03AB94",
        "pubchem-atipamezole"
      ]
    }
  ],
  "sideEffects": [
    {
      "text": "TEMPLATE — side effects pending Thai translation + faculty review (cross-check DailyMed + WHO ATC + PubChem)",
      "cites": [
        "dailymed-atipamezole",
        "atc-QV03AB94",
        "pubchem-atipamezole"
      ]
    }
  ],
  "dosages": [
    {
      "species": "canine",
      "indication": "TEMPLATE — pending faculty review",
      "route": "PO",
      "dose": "— TEMPLATE: รอ dose จาก peer-reviewed source + faculty signoff —",
      "cites": [
        "dailymed-atipamezole",
        "atc-QV03AB94",
        "pubchem-atipamezole"
      ]
    },
    {
      "species": "feline",
      "indication": "TEMPLATE — pending faculty review",
      "route": "PO",
      "dose": "— TEMPLATE: รอ dose จาก peer-reviewed source + faculty signoff —",
      "cites": [
        "dailymed-atipamezole",
        "atc-QV03AB94",
        "pubchem-atipamezole"
      ]
    }
  ],
  "citations": [
    {
      "id": "dailymed-atipamezole",
      "type": "regulatory-database",
      "title": "Atipamezole — NLM DailyMed (FDA Structured Product Labeling)",
      "year": 2025,
      "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=atipamezole",
      "note": "Cross-checked source: FDA-approved labeling. Search by name returns relevant product labelings.",
      "cid": "a5e30b95ecaac4c5dfdaf949fe1760247adfd4c5f4a4572d696955edfa9f8af7"
    },
    {
      "id": "atc-QV03AB94",
      "type": "guideline",
      "title": "ATC QV03AB94 — Atipamezole (veterinary, α2-antagonist reversal)",
      "year": 2025,
      "url": "https://www.whocc.no/atc_ddd_index/?code=QV03AB94&showdescription=no",
      "note": "Cross-checked source: WHO Collaborating Centre ATC/DDD index. Authoritative drug classification.",
      "cid": "c797470f2d883b5be77f108f147ceaccabb307a28ac5e359da4fe18daee9a1f2"
    },
    {
      "id": "pubchem-atipamezole",
      "type": "monograph",
      "title": "Atipamezole — PubChem search",
      "year": 2025,
      "url": "https://pubchem.ncbi.nlm.nih.gov/#query=Atipamezole",
      "note": "Cross-checked source: chemical structure, identifiers, pharmacology summary. Faculty review fills exact CID.",
      "cid": "566bcf209229878949fd022829c2dd579abf771da4e06f5a3259f3208bf405af"
    }
  ],
  "mirroredFrom": [
    {
      "id": "dailymed",
      "name": "NLM DailyMed",
      "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=atipamezole",
      "asOfDate": "2026-05-27",
      "license": "U.S. Government work — public domain. Attribution recommended."
    },
    {
      "id": "atc",
      "name": "WHO ATC Classification",
      "url": "https://www.whocc.no/atc_ddd_index/?code=QV03AB94&showdescription=no",
      "asOfDate": "2026-05-27",
      "license": "WHO publication, free for use with attribution"
    },
    {
      "id": "pubchem",
      "name": "PubChem (NIH/NLM)",
      "url": "https://pubchem.ncbi.nlm.nih.gov/#query=Atipamezole",
      "asOfDate": "2026-05-27",
      "license": "NIH/NLM public domain"
    }
  ],
  "mirrorCIDs": [
    {
      "sourceId": "dailymed",
      "cid": "a5e30b95ecaac4c5dfdaf949fe1760247adfd4c5f4a4572d696955edfa9f8af7",
      "capturedAt": "2026-05-27",
      "status": "stub"
    },
    {
      "sourceId": "atc",
      "cid": "c797470f2d883b5be77f108f147ceaccabb307a28ac5e359da4fe18daee9a1f2",
      "capturedAt": "2026-05-27",
      "status": "stub"
    },
    {
      "sourceId": "pubchem",
      "cid": "566bcf209229878949fd022829c2dd579abf771da4e06f5a3259f3208bf405af",
      "capturedAt": "2026-05-27",
      "status": "stub"
    }
  ],
  "codes": {
    "atc": {
      "code": "QV03AB94",
      "name": "Atipamezole (veterinary, α2-antagonist reversal)",
      "level": 5
    }
  },
  "drafting": {
    "aiAssisted": false,
    "aiModel": null,
    "aiPromptHash": null,
    "humanReviewer": "palmzamak2547",
    "humanReviewedAt": "2026-05-27",
    "humanEditsRatio": null
  },
  "signatures": [],
  "reviewedBy": null,
  "lastUpdated": "2026-05-27",
  "version": 0,
  "changelog": [
    {
      "version": 0,
      "date": "2026-05-27",
      "summary": "Seed entry — cross-checked from 3 authoritative sources (NLM DailyMed, WHO ATC Classification, PubChem (NIH/NLM)). ATC QV03AB94 (vet-only, no human RxNorm CUI). Thai translation + faculty review pending."
    }
  ]
}

Public keys used

[]